{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Caguas",
      "state": "PR",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "76020",
      "recalling_firm": "Mylan LLC.",
      "address_1": "Road #156, Km. 58.8, Lot 24B",
      "address_2": "N/A",
      "postal_code": "00725",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "N/A",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0444-2017",
      "product_description": "Temozolomide Capsules, 250 mg, 5-count bottles, Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 USA, NDC 0378-5265-98.",
      "product_quantity": "588 bottles",
      "reason_for_recall": "Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.",
      "recall_initiation_date": "20161220",
      "center_classification_date": "20170125",
      "termination_date": "20180125",
      "report_date": "20170201",
      "code_info": "LOT #: 2006912, Exp 02/18"
    }
  ]
}